HomeCompareIRMTF vs PFE

IRMTF vs PFE: Dividend Comparison 2026

IRMTF yields 1.51% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $24.9K in total portfolio value· pulled ahead in Year 9
10 years
IRMTF
IRMTF
● Live price
1.51%
Share price
$33.24
Annual div
$0.50
5Y div CAGR
14.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$728.42
Full IRMTF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — IRMTF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIRMTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IRMTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IRMTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IRMTF
Annual income on $10K today (after 15% tax)
$128.26/yr
After 10yr DRIP, annual income (after tax)
$619.16/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,700.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IRMTF + PFE for your $10,000?

IRMTF: 50%PFE: 50%
100% PFE50/50100% IRMTF
Portfolio after 10yr
$37.1K
Annual income
$13,493.57/yr
Blended yield
36.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

IRMTF
No analyst data
Altman Z
2.8
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IRMTF buys
0
PFE buys
0
No recent congressional trades found for IRMTF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIRMTFPFE
Forward yield1.51%6.13%
Annual dividend / share$0.50$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR14.8%13.2%
Portfolio after 10y$24.6K$49.6K
Annual income after 10y$728.42$26,258.71
Total dividends collected$3.9K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IRMTF vs PFE ($10,000, DRIP)

YearIRMTF PortfolioIRMTF Income/yrPFE PortfolioPFE Income/yrGap
1$10,873$173.23$9,153$693.39+$1.7KIRMTF
2$11,836$202.08$8,593$849.25+$3.2KIRMTF
3$12,901$236.02$8,336$1,066.78+$4.6KIRMTF
4$14,080$276.00$8,437$1,384.80+$5.6KIRMTF
5$15,389$323.18$9,013$1,875.40+$6.4KIRMTF
6$16,845$378.97$10,306$2,680.72+$6.5KIRMTF
7$18,469$445.08$12,820$4,101.38+$5.6KIRMTF
8$20,286$523.56$17,673$6,826.70+$2.6KIRMTF
9← crossover$22,323$616.97$27,543$12,591.86$5.2KPFE
10$24,614$728.42$49,560$26,258.71$24.9KPFE

IRMTF vs PFE: Complete Analysis 2026

IRMTFStock

Information Services Corporation provides registry and information management services for public data and records in Canada. It operates through three segments: Registry Operations, Services, and Technology Solutions. The company provides land titles registry services that issues titles to land and registers transactions affecting titles; land surveys services, which registers land survey plans and creates a representation of Saskatchewan land parcels in the cadastral parcel mapping system; and geomatics services that manages geographic data in relation to the cadastral parcel mapping system. It also offers personal property registry services in which security interests and other interests in personal property are registered; and corporate registry for registering business corporations, non-profit corporations, co-operatives, sole proprietorships, partnerships, and business names. In addition, the company provides nationwide search, business name registration, and corporate filing services; corporate minute books, corporate seals/embossers, by-laws and share certificates, and rubber and self-inking stamps; Know-Your-Customer and collateral management services; and public records search services, which includes corporate profiles, business name, NUANS, PPSA, security, and real estate searches, as well as birth, death, and marriage certificate searches. Further, it offers security searches for present and historical information relating to debts and liabilities, pending and potential lawsuits, bankruptcy, liens, judgments, and sales of assets; recovery solutions that aids in facilitating and coordinating asset recovery; and RegSys, a multi-register platform. The company was formerly known as Saskatchewan Land Information Services Corporation and changed its name to Information Services Corporation in November 2000. Information Services Corporation was founded in 2000 and is headquartered in Regina, Canada.

Full IRMTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this IRMTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IRMTF vs SCHDIRMTF vs JEPIIRMTF vs OIRMTF vs KOIRMTF vs MAINIRMTF vs JNJIRMTF vs MRKIRMTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.